STRO - Sutro Biopharma, Inc. Stock Price and Quote

STRO [NASD]

Index	-	P/E	-	EPS (ttm)	-2.59	Insider Own	0.10%	Shs Outstand	57.48M	Perf Week	-7.33%
Market Cap	269.59M	Forward P/E	-	EPS next Y	-2.82	Insider Trans	0.00%	Shs Float	54.06M	Perf Month	-19.46%
Income	-122.70M	PEG	-	EPS next Q	-0.62	Inst Own	91.30%	Short Float / Ratio	2.92% / 3.02	Perf Quarter	-32.82%
Sales	69.80M	P/S	3.86	EPS this Y	-132.00%	Inst Trans	13.21%	Short Interest	1.58M	Perf Half Y	-13.25%
Book/sh	4.39	P/B	1.07	EPS next Y	-17.00%	ROA	-34.30%	Target Price	22.12	Perf Year	-44.26%
Cash/sh	5.65	P/C	0.83	EPS next 5Y	-	ROE	-53.80%	52W Range	3.33 - 9.16	Perf YTD	-42.88%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-35.50%	52W High	-49.62%	Beta	0.93
Dividend %	-	Quick Ratio	5.90	Sales past 5Y	0.70%	Gross Margin	-	52W Low	38.59%	ATR	0.33
Employees	259	Current Ratio	5.90	Sales Q/Q	195.30%	Oper. Margin	-	RSI (14)	24.26	Volatility	6.00% 6.09%
Optionable	Yes	Debt/Eq	0.08	EPS Q/Q	44.40%	Profit Margin	-	Rel Volume	0.32	Prev Close	4.70
Shortable	Yes	LT Debt/Eq	0.03	Earnings	-	Payout	-	Avg Volume	523.84K	Price	4.61
Recom	1.80	SMA20	-12.70%	SMA50	-25.96%	SMA200	-26.46%	Volume	139,519	Change	-1.81%

Mar-21-23

Downgrade

Wells Fargo

Overweight → Equal Weight

$15 → $8

Aug-18-22

Resumed

Wells Fargo

Overweight

$15

Jun-18-21

Initiated

H.C. Wainwright

Buy

$35

Dec-03-20

Initiated

Stifel

Buy

$25

Sep-02-20

Initiated

Jefferies

Buy

$21

Jul-16-20

Initiated

Wells Fargo

Overweight

$18

Jan-13-20

Initiated

SunTrust

Buy

$18

Oct-07-19

Initiated

BTIG Research

Buy

$19

Jul-18-19

Initiated

Deutsche Bank

Buy

$22

Apr-29-19

Initiated

H.C. Wainwright

Buy

$18

Show Previous Ratings

Mar-17-23 04:01PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Mar-05-23 09:17AM	Sutro Biopharma, Inc. (NASDAQ:STRO) insider upped their holding by 4.3% earlier this year Simply Wall St.
Mar-01-23 08:00AM	Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference GlobeNewswire
Feb-28-23 08:00AM	Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer GlobeNewswire
Feb-17-23 04:01PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
06:31AM	Loading…
Jan-27-23 06:31AM	Are Investors Undervaluing Sutro Biopharma, Inc. (NASDAQ:STRO) By 46%? Simply Wall St.
Jan-10-23 09:06AM	Sutro Biopharma Posts Updated Data From Ovarian Cancer Candidate Benzinga -12.42%
Jan-09-23 04:05PM	Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer GlobeNewswire
Jan-06-23 01:48PM	With 74% ownership of the shares, Sutro Biopharma, Inc. (NASDAQ:STRO) is heavily dominated by institutional owners Simply Wall St.
Jan-04-23 08:00AM	Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-22 08:00AM	Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer GlobeNewswire
Dec-20-22 04:05PM	Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract GlobeNewswire -9.49%
Dec-17-22 07:42AM	Investors in Sutro Biopharma (NASDAQ:STRO) have unfortunately lost 54% over the last year Simply Wall St.
Dec-10-22 10:30AM	Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022 GlobeNewswire
Nov-23-22 07:00AM	Sutro Biopharma to Participate in Upcoming Investor Conferences GlobeNewswire
07:07AM	Loading…
Nov-20-22 07:07AM	Need To Know: Analysts Are Much More Bullish On Sutro Biopharma, Inc. (NASDAQ:STRO) Revenues Simply Wall St.
Nov-11-22 09:55AM	How Much Upside is Left in Sutro Biopharma, Inc. (STRO)? Wall Street Analysts Think 214% Zacks
06:02AM	Sutro Biopharma Third Quarter 2022 Earnings: Misses Expectations Simply Wall St.
Nov-08-22 05:45PM	Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Tops Revenue Estimates Zacks -5.05%
04:30PM	Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones GlobeNewswire
Nov-03-22 09:00AM	Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition GlobeNewswire
Nov-02-22 10:00AM	Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy? Zacks -5.43%
07:00AM	Sutro Biopharma to Participate in Upcoming Investor Conferences GlobeNewswire
Oct-24-22 07:00AM	Sutro Biopharma Announces Departure of Chief Medical Officer GlobeNewswire +14.72%
Oct-21-22 09:55AM	Wall Street Analysts Believe Sutro Biopharma, Inc. (STRO) Could Rally 326%: Here's is How to Trade Zacks
Oct-05-22 09:55AM	Does Sutro Biopharma, Inc. (STRO) Have the Potential to Rally 293% as Wall Street Analysts Expect? Zacks
Sep-26-22 09:39AM	A Sutro Biopharma, Inc. (NASDAQ:STRO) insider increased their holdings by 4.3% last year Simply Wall St.
Sep-19-22 11:58AM	bluebird's (BLUE) Gene Therapy Gets FDA Nod for CALD Zacks
Sep-01-22 07:00AM	Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference GlobeNewswire
Aug-29-22 09:55AM	How Much Upside is Left in Sutro Biopharma, Inc. (STRO)? Wall Street Analysts Think 288% Zacks
04:01PM	Loading…
Aug-19-22 04:01PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-11-22 09:55AM	Wall Street Analysts Think Sutro Biopharma, Inc. (STRO) Could Surge 295%: Read This Before Placing a Bet Zacks
06:31AM	New Forecasts: Here's What Analysts Think The Future Holds For Sutro Biopharma, Inc. (NASDAQ:STRO) Simply Wall St.
Aug-08-22 06:05PM	Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates Zacks +7.47%
04:30PM	Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones GlobeNewswire
Aug-03-22 07:00AM	Sutro Biopharma to Present at the 2022 Wedbush PacGrow Healthcare Conference GlobeNewswire
Jul-28-22 08:07AM	Is Sutro Biopharma (NASDAQ:STRO) Using Too Much Debt? Simply Wall St. -5.63%
Jul-26-22 04:01PM	Sutro Biopharma Achieves First in Human Milestone in Cytokine Derivatives Collaboration with Merck GlobeNewswire
Jul-12-22 07:00AM	Sutro Biopharma Announces Virtual Deep Dive Research Forum: Next-Gen Innovations in ADCs GlobeNewswire
Jun-29-22 11:51AM	Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More Zacks
Jun-28-22 12:25PM	Sutro Biopharma (STRO) Up 50% on Cancer Treatment Collaboration Zacks +20.79%
07:25AM	Sutro Biopharma Stock Surges On Cancer Treatment Pact Benzinga
Jun-27-22 07:31PM	Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs) GlobeNewswire
07:30PM	Astellas and Sutro Biopharma Announce Worldwide Strategic Collaboration to Advance Novel Immunostimulatory Antibody-Drug Conjugates (iADCs) PR Newswire
Jun-03-22 04:01PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-02-22 07:00AM	Sutro Biopharma to Participate in Upcoming Investor Conferences GlobeNewswire
May-14-22 08:02AM	Revenue Downgrade: Here's What Analysts Forecast For Sutro Biopharma, Inc. (NASDAQ:STRO) Simply Wall St.
May-09-22 05:45PM	Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Misses Revenue Estimates Zacks -12.06%
04:30PM	Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones GlobeNewswire
May-05-22 05:35PM	Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates Zacks -7.20%
10:09AM	Is a Surprise Coming for Sutro Biopharma (STRO) This Earnings Season? Zacks
Apr-29-22 05:00PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
03:00PM	Sutro Biopharma, Inc. (STRO) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Apr-19-22 09:30AM	Sutro Biopharma, Inc. (NASDAQ:STRO) drops to US$316m and insiders who purchased earlier this year lose another US$9.4k Simply Wall St.
Apr-08-22 01:00PM	Sutro Biopharma Presents Nonclinical Data for Antibody-Drug Conjugate STRO-002 at the AACR Annual Meeting 2022 PR Newswire
Apr-05-22 07:00AM	Sutro Biopharma to Present at the 21st Annual Needham Virtual Healthcare Conference PR Newswire
Mar-30-22 04:05PM	Sutro Biopharma Presented on Advances in Novel Immunostimulatory Antibody-Drug Conjugate Modality at the 12th Annual World ADC PR Newswire
Mar-21-22 01:39PM	Sutro Biopharma, Inc. (STRO) Moves 6.4% Higher: Will This Strength Last? Zacks -17.84%
Mar-03-22 07:00AM	Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference PR Newswire
Feb-28-22 04:35PM	Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones PR Newswire
Feb-18-22 11:21AM	Does Sutro Biopharma (NASDAQ:STRO) Have A Healthy Balance Sheet? Simply Wall St.
Feb-17-22 02:38AM	Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs Samsara BioCapital Insider Monkey
Jan-07-22 08:48AM	Implied Volatility Surging for Sutro Biopharma (STRO) Stock Options Zacks
Jan-06-22 04:34PM	Sutro Biopharma Collapses; Why One Analyst Remains Bullish On Its Chances In Cancer Investor's Business Daily -27.87%
12:37PM	Why Sutro Biopharma Stock Is Losing Ground Today Motley Fool
07:00AM	Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference PR Newswire
Jan-05-22 04:30PM	Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer PR Newswire
Dec-27-21 07:00AM	Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer PR Newswire
07:00AM	Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China PR Newswire
Dec-17-21 01:38PM	Is Sutro Biopharma, Inc. (STRO) Going to Burn These Hedge Funds? Insider Monkey +5.19%
Dec-13-21 07:00AM	Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021 PR Newswire
Nov-22-21 07:00AM	Sutro Biopharma to Participate in Two Upcoming Investor Conferences PR Newswire
Nov-17-21 07:00AM	Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors PR Newswire
Nov-10-21 08:55AM	Sutro Biopharma, Inc. (STRO) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:00AM	Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones PR Newswire
Nov-02-21 07:00AM	Sutro Biopharma to Participate in Three Upcoming Investor Conferences PR Newswire
Oct-28-21 03:05PM	Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for Zacks +5.13%
Oct-19-21 11:19AM	Should I Avoid Sutro Biopharma, Inc. (STRO)? Insider Monkey
Oct-13-21 03:07AM	Sutro Biopharma, BioNova Pharmaceuticals Join Hands in Greater China SmarterAnalyst
Oct-12-21 07:00AM	Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China PR Newswire
Sep-30-21 09:18AM	Merck, Sutro Biopharma Extends Cytokine Derivative Research Program Benzinga
07:00AM	Sutro Biopharma Announces Extension of Cytokine Derivative Research Program Under Collaboration with Merck PR Newswire
Sep-29-21 10:26AM	Chief Port. Strat And Alnce Ofcr Of Sutro Biopharma Trades $112 Thousand In Company Stock Benzinga
08:47AM	15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs Samsara BioCapital Insider Monkey
Sep-17-21 05:00PM	Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
Sep-16-21 07:00AM	Sutro Biopharma Announces Expansion of Leadership Team PR Newswire
Sep-01-21 07:00AM	Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference PR Newswire
Aug-19-21 09:35AM	Sutro (STRO) Ovarian Cancer Drug Gets FDA's Fast Track Tag Zacks
07:02AM	New Forecasts: Here's What Analysts Think The Future Holds For Sutro Biopharma, Inc. (NASDAQ:STRO) Simply Wall St.
Aug-18-21 07:37AM	The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga
07:00AM	Sutro Biopharma Announces STRO-002 FDA Fast Track Designation for Patients with Advanced Ovarian Cancer PR Newswire
Aug-11-21 08:12AM	Is Sutro Biopharma (NASDAQ:STRO) A Risky Investment? Simply Wall St.
Aug-09-21 08:35AM	Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:05AM	Sutro Biopharma Reports Second Quarter 2021 Financial Results, Business Highlights and Anticipated Second Half 2021 Milestones PR Newswire
07:00AM	Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer PR Newswire
Aug-05-21 10:50AM	10 Best Biotech Stocks to Buy According to Alan Fraziers Frazier Healthcare Partners Insider Monkey +7.42%
Jul-29-21 03:05PM	Will Sutro Biopharma, Inc. (STRO) Report Negative Q2 Earnings? What You Should Know Zacks
07:00AM	Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference PR Newswire
Jul-13-21 11:11AM	Is Sutro Biopharma, Inc. (STRO) A Good Stock To Buy? Insider Monkey
Jun-21-21 04:42PM	Sutro Biopharma, Inc. (STRO) Surges 6.4%: Is This an Indication of Further Gains? Zacks

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ALBINI EDWARD C	CFO and Secretary	Feb 13	Option Exercise	5.81	45,698	265,414	76,406	Feb 14 05:12 PM
NEWELL WILLIAM J	CEO	Jan 27	Option Exercise	0.00	13,750	0	137,787	Jan 31 05:31 PM
FITZPATRICK LINDA A	Chief People & Comm. Officer	Jan 27	Option Exercise	0.00	8,250	0	44,574	Jan 31 05:29 PM
Hallam Trevor	Pres. Rsrch & Cf. Sctific Ofcr	Jan 27	Option Exercise	0.00	5,250	0	85,521	Jan 31 05:27 PM
Vasquez Nicki	Chief Port. Strat & Alnce Ofcr	Jan 27	Option Exercise	0.00	2,500	0	16,620	Jan 31 05:24 PM
Shabbir Anik	Chief Technical Ops. Officer	Jan 27	Option Exercise	0.00	4,500	0	32,259	Jan 31 05:21 PM
ALBINI EDWARD C	CFO and Secretary	Jan 27	Option Exercise	0.00	5,250	0	32,848	Jan 31 05:19 PM
Chung Jane	Chief Commercial Officer	Aug 09	Option Exercise	0.00	18,750	0	21,250	Aug 10 06:16 PM
Vasquez Nicki	Chief Port. Strat & Alnce Ofcr	Jul 12	Option Exercise	0.00	3,250	0	15,243	Jul 13 06:24 PM
Hallam Trevor	Pres. Rsrch & Cf. Sctific Ofcr	Apr 14	Option Exercise	0.00	3,750	0	81,567	Apr 15 07:19 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience